PhD student Kezia Gitareja is studying a new way to stop multiple myeloma, a type of blood cancer that affects the cells in our bone marrow. In a recent study, Kezia showed that certain drugs that target ribosome production kill myeloma cells, even in cases where the disease has come back after treatment. Now, she’s using advanced tools to find out how these drugs work and how they could be improved for future treatments. Find out how Kezia is working to shut down cancer's protein factories: https://lnkd.in/g5NfFHUh
